OK, You want to debate President Obama? Fine. Let’s

New Post Public Reply Private Reply Replies (4) Message Board
Goodspeed65 Lmcat #61668
229
OK, You want to debate President Obama? Fine. Let’s debate President Obama. How many investigations did Obama have in his eight years? Zero. How many indictments within his cabinet? Zero. How many tweet storms acting as a juvenile delinquent? Zero. How many tax returns did he hide? Zero. How many court cases came up against him where he settled for fraud? Zero. Trump we know has one already. How many times has Obama been labeled as “Individual one”? Zero. How many corpses has Obama denigrated? Zero. Trump, we know has McCain on his brain, and is a bigger POS then he already is for denigrating him in death. How many times has Obama asked his supporters to commit acts of violence? Zero. We know Trump has told his supporters to knock people out and he’d pay the legal fees. How many times has Obama called the United States foolish in front of Vlad Putin? Zero. We’ve seen the coward Trump do so on National TV. How many times has Obama cheated on his wife with porn stars? Zero. Trump. At least Stormy and probably others.

When I tell you, you’ve got nothing. I mean you actually have less then zero. Not one of your conspiracy theories, not one of your Internet rumors, not one of your “explosive” news reports has amounted to shit.

I’d prepare to bunker up, because Obama won’t be the last black man to run for President and more then likely not the last one to win either.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Monitor Class Action Against Xerox Ahead of Deadline

Updated Category News Views 313

Xerox Holdings Corporation Under Legal Scrutiny Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors of Xerox Holdings Corporation (NASDAQ: XRX) to inform them about an ongoing class action lawsuit. Investors are reminded of an important deadline for those wanting to assume the role of lead plaintiff in this case. The deadline for...

Continue Reading
UBS's Caution on Dr. Reddy's Projections Signals Concerns

Updated Category News Views 155

UBS dropped a Sell rating on Dr. Reddy's Laboratories (NSE: DRRD) back in 2024, tagging the stock with a price target of INR 5,700.00. You could feel the tension shift in trading rooms as their assessment sparked fresh chatter about the firm’s US base business revenue projections that seem downright optimistic. UBS Questions Revenue Estimates: Too High or Just Right?...

Continue Reading
Evaluating Apple's Business Landscape Among Top Tech Firms

Updated Category News Views 115

Assessing Market Position and Performance In the dynamic world of technology hardware, it’s crucial for investors to analyze the competition thoroughly. This article takes a closer look at Apple (NASDAQ: AAPL) and compares its financial metrics and market position against its key competitors in the industry. With this analysis, we aim to provide insights into Apple's...

Continue Reading
Back to School: Parents Prepare for Illness and Solutions

Updated Category News Views 191

Back to School: Parents Brace for Sickness A recent survey shows that as children head back to the classroom, many parents anticipate facing a wave of illnesses at home. Conducted by Boiron, a leader in homeopathic remedies, this nationwide survey reveals parents' concerns about the inevitable germs that come along with the school year. Survey Insights on Parental...

Continue Reading
Scarf Systems Achieves SOC 2 Type 2 Examination Success

Updated Category News Views 72

Scarf Systems, Inc. completed a SOC 2 Type 2 examination back in early 2023, solidifying its place as a frontrunner in data security. This wasn't just some routine check; it was a deep dive into how well Scarf protected customer data and adhered to stringent safety protocols. But here’s the kicker—traders started asking: is this enough to keep investors calm? What’s...

Continue Reading